Neuronetics, Inc. (STIM) Dividend History

Neuronetics, Inc. is a medical technology company specializing in developing and commercializing neurostimulation devices for the treatment of mental health and neurological conditions. The company is best known for its NeuroStar Advanced Therapy System, which offers non-invasive transcranial magnetic stimulation (TMS) therapy primarily for the treatment of major depressive disorder. Neuronetics aims to provide innovative solutions that improve patient outcomes and expand access to mental health treatments.

3222 Phoenixville Pike, Malvern, PA, 19355
Phone: 877-600-7555
Website:

Dividend History

Neuronetics, Inc. currently does not pay dividends

Company News

  • Neuronetics and Greenbrook TMS Announce Closing of Transaction

    Neuronetics, Inc. has successfully completed the acquisition of Greenbrook TMS Inc. The combined company will continue to operate as Neuronetics, Inc. and the Neuronetics shares will continue to trade on the NASDAQ Global Market under the ticker 'STIM'.

    GlobeNewswire Inc.
  • Neuronetics (STIM) Expands NeuroStar Portfolio With New Launch

    Neuronetics (STIM) announces the nationwide launch of the Better Me Provider (BMP) program developed in collaboration with TMS medical experts. The BMP program will be part of the company's NeuroStar product line.

    Zacks Investment Research
    Featured Companies: HIMS JYNT MEDP
  • NeuroStar® Launches Better Me Provider Program Nationwide

    The first and only TMS company to establish comprehensive standards for patient care and responsiveness in the mental health industry The first and only TMS company to establish comprehensive standards for patient care and responsiveness in the mental health industry

    GlobeNewswire Inc.
  • NeuroStar Showcases Cutting-Edge Research at Clinical TMS Society Annual Meeting

    Early prediction of nonresponse abstract selected for oral presentation as a prestigious Top 4 Abstract at CTMSS 2024 Early prediction of nonresponse abstract selected for oral presentation as a prestigious Top 4 Abstract at CTMSS 2024

    GlobeNewswire Inc.
  • Neuronetics to Present at the William Blair 44th Annual Growth Stock Conference

    MALVERN, Pa., May 23, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced that the management team will present at the William Blair 44th Annual Growth Stock Conference on Thursday, June 6, 2024. The Company is scheduled to present at 10:00am Central Time the same day via webcast.

    GlobeNewswire Inc.
Dividend data last updated 06/07/2025 04:17:37 UTC